Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine
- 20 October 1999
- Vol. 34 (4) , 313-318
- https://doi.org/10.1002/(sici)1098-2396(19991215)34:4<313::aid-syn7>3.0.co;2-1
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- [3H]DOPA Formed from [3H]Tyrosine in Living Rat Brain Is Not Committed to Dopamine SynthesisJournal of Cerebral Blood Flow & Metabolism, 1998
- On the accuracy of an [18F]FDOPA compartmental model: evidence for vesicular storage of [18F]fluorodopamine in vivoJournal of Neuroscience Methods, 1997
- Regulation of DOPA Decarboxylase Activity in Brain of Living RatJournal of Neurochemistry, 1995
- The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementiasBrain Research Reviews, 1995
- Are NMDA antagonistic properties relevant for antiparkinsonianlike activity in rats?—Case of amantadine and memantineJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994
- MRI-PET Correlation in Three Dimensions Using a Volume-of-Interest (VOI) AtlasJournal of Cerebral Blood Flow & Metabolism, 1991
- The functional anatomy of basal ganglia disordersTrends in Neurosciences, 1989
- Altered metabolism of [18F]-6-fluorodopa in the hooded rat following inhibition of catechol-O-methyltransferase with U-0521Biochemical Pharmacology, 1987
- The Metabolism of [18F]6‐Fluoro‐l‐3,4‐Dihydroxyphenylalanine in the Hooded RatJournal of Neurochemistry, 1987
- Use of Amantadine in Parkinson's Disease. Results of a Double-blind TrialBMJ, 1970